Earlier this morning, House Bill 1754 was voted out of the Senate Banking & Insurance Committee. This legislation, which aims to ensure that biomarker testing is covered by Medicaid and all other state-regulated insurance plans when patients need it, now advances to the Senate floor for consideration.